{"transactions":[{"id":689284,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24132,"kind":"person","name":"Patel Tushar Bhikhubhai","position":1,"cik":"0001745375","reported_name":"Patel Tushar Bhikhubhai","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-12T22:06:35.000Z","date":"2026-08-10","kind":"grant","planned":false,"acquired":true,"shares":12763469,"ownership":{"direct":false,"nature":"By Limited Liability Companies Controlled by Family Trusts"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the \"Purchase Agreement\"), by and among the Issuer, Kashiv BioSciences, LLC (\"Kashiv\"), KB Seller Representative, LLC and the equityholders of Kashiv named therein (the \"Sellers\"), a subsidiary of the Issuer purchased (the \"Acquisition\") from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (\"Class A Common Stock\").  Pursuant to the terms of the Purchase Agreement, a limited liability company managed by the Reporting Person received 12,763,469 shares of Class A Common Stock in the Acquisition."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the \"Purchase Agreement\"), by and among the Issuer, Kashiv BioSciences, LLC (\"Kashiv\"), KB Seller Representative, LLC and the equityholders of Kashiv named therein (the \"Sellers\"), a subsidiary of the Issuer purchased (the \"Acquisition\") from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (\"Class A Common Stock\").  Pursuant to the terms of the Purchase Agreement, a limited liability company managed by the Reporting Person received 12,763,469 shares of Class A Common Stock in the Acquisition."}],"balance_after":61341678,"source":{"system":"sec-edgar","filing":"0000898432-26-000655","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089843226000655/form4.xml","form_type":"4"}},{"id":1203832,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24132,"kind":"person","name":"Patel Tushar Bhikhubhai","position":1,"cik":"0001745375","reported_name":"Patel Tushar Bhikhubhai","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2025-03-17T20:51:24.000Z","date":"2025-03-14","kind":"sale","planned":false,"acquired":false,"shares":5000000,"price":8.35,"value":41750000.0,"ownership":{"direct":false,"nature":"By a Limited Liability Company Controlled by a Family Trust"},"balance_after":48578209,"source":{"system":"sec-edgar","filing":"0000898432-25-000191","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089843225000191/form4.xml","form_type":"4"}},{"id":1746811,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24132,"kind":"person","name":"Patel Tushar Bhikhubhai","position":1,"cik":"0001745375","reported_name":"Patel Tushar Bhikhubhai","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock and Common Units","published_at":"2023-11-08T23:22:20.000Z","date":"2023-11-07","kind":"other","planned":false,"acquired":false,"shares":53578209,"ownership":{"direct":false,"nature":"By Family Trusts"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Issuer of the Common Units is Amneal Pharmaceuticals, LLC."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":53578209},"source":{"system":"sec-edgar","filing":"0001209191-23-054742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123054742/doc4.xml","form_type":"4"}},{"id":1746810,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24132,"kind":"person","name":"Patel Tushar Bhikhubhai","position":1,"cik":"0001745375","reported_name":"Patel Tushar Bhikhubhai","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-11-08T23:22:20.000Z","date":"2023-11-07","kind":"other","planned":false,"acquired":true,"shares":53578209,"ownership":{"direct":false,"nature":"By Family Trusts"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On November 7, 2023, Amneal Pharmaceuticals, Inc. (formerly known as Amneal NewCo Inc.) (the \"Issuer\") became the successor of Amneal Intermediate Inc. (formerly known as Amneal Pharmaceuticals, Inc.) (\"Old PubCo\") pursuant to merger transactions, in which a subsidiary of the Issuer merged with and into Old PubCo with Old PubCo surviving and, immediately following such merger, a subsidiary of the Issuer merged with and into Amneal Pharmaceuticals, LLC (\"AP\"), an indirect subsidiary of the Issuer, with AP surviving. The transactions resulted in the Issuer becoming a parent holding company of Old PubCo and AP. As a result of the transactions, there is a single class of stock of the Issuer outstanding, and the proportionate economic and voting rights of security holders in the Issuer are identical to the direct and indirect economic and voting rights held in Old PubCo and AP prior to the transactions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) (\"AP Units\") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration."}],"balance_after":53578209,"source":{"system":"sec-edgar","filing":"0001209191-23-054742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123054742/doc4.xml","form_type":"4"}}]}